These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Case report: use of topical tranexamic acid to stop localised bleeding. Noble S; Chitnis J Emerg Med J; 2013 Jun; 30(6):509-10. PubMed ID: 22833592 [TBL] [Abstract][Full Text] [Related]
9. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser. Kato H; Araki J; Eto H; Doi K; Hirai R; Kuno S; Higashino T; Yoshimura K Dermatol Surg; 2011 May; 37(5):605-10. PubMed ID: 21457392 [TBL] [Abstract][Full Text] [Related]
10. An alternative perspective to just halting tranexamic acid utilization in gastrointestinal bleeding. Gilbert BW; Rech MA Am J Emerg Med; 2021 Aug; 46():781-782. PubMed ID: 32950320 [No Abstract] [Full Text] [Related]
11. Tranexamic acid in trauma: how should we use it? Napolitano LM; Cohen MJ; Cotton BA; Schreiber MA; Moore EE J Trauma Acute Care Surg; 2013 Jun; 74(6):1575-86. PubMed ID: 23694890 [No Abstract] [Full Text] [Related]
12. Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review. Peng M; Guo X; Yi F; Romeiro FG; Mancuso A; Qi X Adv Ther; 2021 Oct; 38(10):5065-5077. PubMed ID: 34524644 [TBL] [Abstract][Full Text] [Related]
13. Intralesional tranexamic acid in treatment of telangiectasia: reversible effect and resistance to therapy. Ayhan E Clin Exp Dermatol; 2019 Jul; 44(5):e209-e210. PubMed ID: 30913310 [No Abstract] [Full Text] [Related]
14. Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease. Davis NF; McGuire BB; Lawlor L; O'Gorman P; O'Malley KJ; Fitzpatrick JM Ann Hematol; 2010 Nov; 89(11):1179-80. PubMed ID: 20358201 [No Abstract] [Full Text] [Related]
15. Topical 5% tranexamic acid for acne-related postinflammatory erythema. Jakhar D; Kaur I J Am Acad Dermatol; 2020 Jun; 82(6):e187-e188. PubMed ID: 31589950 [No Abstract] [Full Text] [Related]
16. Use of oral therapy for the prevention of postinflammatory hyperpigmentation. McDaniel DH Dermatol Surg; 2011 May; 37(5):611. PubMed ID: 21518099 [No Abstract] [Full Text] [Related]
18. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options. Flanagan BA; Collins C; Parra S Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728 [TBL] [Abstract][Full Text] [Related]
19. [Tranexamic acid--an old drug in a new costume. Multinational studies and new texts provide a boost for the antifibrinolytic agent]. Tengborn L; Berntorp E Lakartidningen; 2013 Aug 21-Sep 3; 110(34-35):1458-9. PubMed ID: 24044180 [No Abstract] [Full Text] [Related]
20. Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding. Moore KA; Callahan TS; Maison-Blanche P; Morin I; Marenco T; Swearingen D; Olbertz J Expert Opin Pharmacother; 2010 Oct; 11(14):2281-90. PubMed ID: 20698724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]